With the growing awareness of the cumulative effects of x-ray radiation, new imaging technologies are being developed to reduce the exposure risk. A new imaging device called SoftScan has recently been approved by Health Canada for breast cancer detection.

SoftScan is a non-invasive and painless optical imaging technology, which enables the characterization of breast tumours by clinicians as benign or malignant, without exposing the patients to radiation.

• Dr. Joe Kozikowski, Chief Medical Officer of ART Advanced Research Technologies Inc